168 related articles for article (PubMed ID: 2117219)
21. [Morphology, pathogenesis and classification of interstitial lung diseases].
Strukov AI; Paukov VS; Orekhov OO
Arkh Patol; 1984; 46(7):3-14. PubMed ID: 6383289
[TBL] [Abstract][Full Text] [Related]
22. Tenascin immunoreactivity in cryptogenic fibrosing alveolitis.
Wallace WA; Howie SE; Lamb D; Salter DM
J Pathol; 1995 Apr; 175(4):415-20. PubMed ID: 7540684
[TBL] [Abstract][Full Text] [Related]
23. Expression of tumour necrosis factor-alpha in cryptogenic fibrosing alveolitis.
Nash JR; McLaughlin PJ; Butcher D; Corrin B
Histopathology; 1993 Apr; 22(4):343-7. PubMed ID: 8514277
[TBL] [Abstract][Full Text] [Related]
24. [Value and indications for bronchoalveolar lavage combined with transbronchial lung biopsy].
Popper H; Pongratz M
Wien Klin Wochenschr; 1987 Dec; 99(24):848-55. PubMed ID: 3439184
[TBL] [Abstract][Full Text] [Related]
25. T-cell receptor gene usage in patients with fibrosing alveolitis and control subjects.
Lympany PA; Southcott AM; Welsh KI; Black CM; Boylston AW; du Bois RM
Eur J Clin Invest; 1999 Feb; 29(2):173-81. PubMed ID: 10093005
[TBL] [Abstract][Full Text] [Related]
26. In vivo levels and in vitro production of interferon-gamma in fibrosing interstitial lung diseases.
Prior C; Haslam PL
Clin Exp Immunol; 1992 May; 88(2):280-7. PubMed ID: 1572093
[TBL] [Abstract][Full Text] [Related]
27. [Cellular composition and T-lymphocyte subpopulations in the bronchoalveolar lavage fluid in patients with fibrosing alveolitis and pulmonary granulomatosis].
Orlova GP; Zhuravlev AV
Klin Med (Mosk); 1990 Jan; 68(1):69-73. PubMed ID: 2335926
[TBL] [Abstract][Full Text] [Related]
28. Alveolar accumulation of hyaluronan and alveolar cellular response in bleomycin-induced alveolitis.
Nettelbladt O; Scheynius A; Bergh J; Tengblad A; Hällgren R
Eur Respir J; 1991 Apr; 4(4):407-14. PubMed ID: 1713172
[TBL] [Abstract][Full Text] [Related]
29. Phenotypic analysis of alveolar macrophages in normal subjects and in patients with interstitial lung disease.
Campbell DA; Poulter LW; Du Bois RM
Thorax; 1986 Jun; 41(6):429-34. PubMed ID: 3787519
[TBL] [Abstract][Full Text] [Related]
30. [Variants and stages in the course of idiopathic fibrosing alveolitis].
Kogan EA; Kornev BM; Salov IuA; Sekamova SM; Shukurova RA; Popova EN; Makarova OV; Bolevich S; Ovchinnikov AA; Kogan AKh
Ter Arkh; 1995; 67(5):71-5. PubMed ID: 7638787
[TBL] [Abstract][Full Text] [Related]
31. Bronchoalveolar macrophages in sarcoidosis and cryptogenic fibrosing alveolitis.
du Bois RM; Townsend PJ; Cole PJ; Haslam PL; Turner-Warwick M
Clin Allergy; 1981 Sep; 11(5):409-19. PubMed ID: 7318160
[TBL] [Abstract][Full Text] [Related]
32. Immunoreactive interleukin 4 and interferon-gamma expression by type II alveolar epithelial cells in interstitial lung disease.
Wallace WA; Howie SE
J Pathol; 1999 Mar; 187(4):475-80. PubMed ID: 10398109
[TBL] [Abstract][Full Text] [Related]
33. Expression of class II MHC antigens on alveolar epithelium in fibrosing alveolitis.
Kallenberg CG; Schilizzi BM; Beaumont F; Poppema S; De Leij L; The TH
Clin Exp Immunol; 1987 Jan; 67(1):182-90. PubMed ID: 3621672
[TBL] [Abstract][Full Text] [Related]
34. B7-1, B7-2 and class II MHC molecules in idiopathic pulmonary fibrosis and bronchiolitis obliterans-organizing pneumonia.
Kaneko Y; Kuwano K; Kunitake R; Kawasaki M; Hagimoto N; Hara N
Eur Respir J; 2000 Jan; 15(1):49-55. PubMed ID: 10678620
[TBL] [Abstract][Full Text] [Related]
35. Mast cells, atypical lymphocytes, and neutrophils in bronchoalveolar lavage in extrinsic allergic alveolitis. Comparison with other interstitial lung diseases.
Haslam PL; Dewar A; Butchers P; Primett ZS; Newman-Taylor A; Turner-Warwick M
Am Rev Respir Dis; 1987 Jan; 135(1):35-47. PubMed ID: 2432812
[TBL] [Abstract][Full Text] [Related]
36. Subclinical alveolitis in immunologic systemic disorders.
Wallaert B
Lung; 1990; 168 Suppl():974-83. PubMed ID: 2117218
[TBL] [Abstract][Full Text] [Related]
37. Neutrophil activation in fibrosing alveolitis: a comparison of lone cryptogenic fibrosing alveolitis and systemic sclerosis.
Cailes JB; O'Connor C; Pantelidis P; Southcott AM; Fitzgerald MX; Black CM; du Bois RM
Eur Respir J; 1996 May; 9(5):992-9. PubMed ID: 8793462
[TBL] [Abstract][Full Text] [Related]
38. In vitro release of interleukin-15 by broncho-alveolar lavage cells and peripheral blood mononuclear cells from patients with different lung diseases.
Zissel G; Bäumer I; Schlaak M; Müller-Quernheim J
Eur Cytokine Netw; 2000 Mar; 11(1):105-12. PubMed ID: 10705307
[TBL] [Abstract][Full Text] [Related]
39. Effect of interstitial lung disease macrophages on T-cell signal transduction.
Weissler JC; Mendelson C; Moya F; Yarbrough WC
Am J Respir Crit Care Med; 1994 Jan; 149(1):191-6. PubMed ID: 8111582
[TBL] [Abstract][Full Text] [Related]
40. Idiopathic pulmonary fibrosis/cryptogenic fibrosing alveolitis.
Fellrath JM; du Bois RM
Clin Exp Med; 2003 Sep; 3(2):65-83. PubMed ID: 14598183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
